Newbury Pharmaceuticals AB
NEWBRY | ST
Overview
Corporate Details
- ISIN(s):
- SE0015244884
- LEI:
- 549300F7XHU3I8CWL373
- Country:
- Sweden
- Address:
- Medicon Village, 223 81 Lund
- Website:
- https://www.newburypharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company founded in 2020. It focuses on building and marketing a portfolio of proprietary and licensed specialty prescription drugs and branded products. The company operates primarily in the Scandinavian market, positioning itself as a local alternative to multinational corporations. Its product pipeline is concentrated on providing treatment solutions within key therapeutic areas, including oncology, rare diseases, and neurology.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Newbury Pharmaceuticals AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2018-10-05 13:14 |
Regulatory News Service
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
|
English | 10.7 KB | |
| 2017-06-29 13:30 |
Report Publication Announcement
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
|
English | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-29 | Johan Strömqvist | Other | Sell | 13,564 | 40,692.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 10,400 | 30,888.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 10,200 | 30,804.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 5,000 | 15,570.50 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 5,000 | 15,200.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 2,436 | 7,332.36 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 100 | 305.00 SEK |
| 2024-08-03 | Andreas Hedskog | Other | Buy | 200,000 | 178,000.00 SEK |
| 2024-08-03 | Andreas Hedskog | Other | Other | 200,000 | N/A |
| 2024-01-22 | Alsakali Equity AB | Other | Buy | 4,000 | 18,920.00 SEK |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
